CB:NYSEChubb Limited Analysis
Data as of 2026-09-10 - not real-time
$337.62
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At $337.62, Chubb Limited shows no decisive moving-average alignment, leaving the trend neutral. The last 30 days have lost 7.1%. RSI sits at 43.9, which reads as neutral, and MACD momentum is bearish. Recent trading has carved out support near $333.63 and resistance around $349.03.
On valuation the read is undervalued — earnings multiple of 11.9 versus a 16.2 sector average, below the peer group. The average analyst target implies 8.4% above today's level. Revenue is growing at 6.1% on a 18.1% profit margin. The 1.21% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 18.0%, a beta of -0.34 and a maximum drawdown of 9.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.
On valuation the read is undervalued — earnings multiple of 11.9 versus a 16.2 sector average, below the peer group. The average analyst target implies 8.4% above today's level. Revenue is growing at 6.1% on a 18.1% profit margin. The 1.21% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 18.0%, a beta of -0.34 and a maximum drawdown of 9.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 6/10 long-term conviction.
Top Market Events
Chubb Limited stock trades around its recent $343.Chubb Limited stock is trading close to $341 after a run of new institutional positions and a recentChubb Limited stock is holding just below its 52-week high, with Wall Street consensus targets still
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Trading above the 200-day average of 326.77
- MACD momentum is negative
- 30-day price change of -7.1%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 11.9 versus sector average of 16.2
- Trading above the 200-day average of 326.77
- Analyst targets imply +8.4% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 11.9 versus sector average of 16.2
- Analyst targets imply +8.4% versus the current price
- Profit margin of 18.1% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth6.10%
Profit Margin18.07%
P/E Ratio11.9
ROE14.82%
ROA3.36%
Debt/Equity30.94
P/B Ratio1.7
Op. Cash Flow$15.4B
Free Cash Flow$10.5B
Industry P/E16.2
Technical Analysis
TrendNeutral
RSI43.9
Support$333.63
Resistance$349.03
MA 20$341.71
MA 50$347.72
MA 200$326.77
MACDBearish
VolumeDecreasing
Fear & Greed Index92.02
Valuation
Fair Value$400.19
Target Price$366.13
Upside/Downside8.44%
GradeUndervalued
TypeBlend
Dividend Yield1.21%
Risk Assessment
Beta-0.34
Volatility17.95%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.